SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to its recent surge, reportedly driven by AI/robotics sector sympathy and a potentially low float. Community members are actively discussing its volatile price action, with some anticipating further upward movement and a possible short squeeze, while others advise caution and profit-taking due to the stock's speculative nature.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors digest recent guidance and await further details on the company's 2026 financial outlook. Community members are actively discussing the potential for growth in new products and speculating on possible acquisitions. Some traders express frustration with the stock's movement, while others highlight its defensive qualities and dividend yield.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as investors digest mixed signals from economic data, including rising unemployment coupled with job additions and soft retail sales, leading to a tug-of-war between bullish and bearish sentiments. Community members are debating the implications for future rate cuts and the overall health of the economy, with some anticipating a recession while others see a bear trap. The ETF's movements are further influenced by speculation around the Federal Reserve's next actions and potential market manipulation.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending due to mixed reactions to its Phase 2b trial results for alopecia areata treatment, rezpegaldesleukin, with discussions focusing on statistical significance after excluding ineligible patients. The community debates the drug's potential and the impact of protocol violations on trial outcomes, while also highlighting its favorable safety profile compared to existing treatments. Speculation about future Phase 3 development and potential market impact is also driving interest.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending amidst a significant price drop, sparking discussions about potential reasons ranging from AI sector concerns to possible manipulation. Community members are debating dip-buying strategies, speculating on news catalysts, and analyzing technical indicators to gauge potential support levels. The focus remains on the long-term potential of Applied Digital and the data center industry.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the Platform and Devices segments. The Platform segment includes digital advertising and related services including the demand-side platform and content distribution services such as subscription and transaction revenue shares, media and entertainment promotional spending, the sale of premium subscriptions, and the sale of branded channel buttons on remote controls. The Devices segment is involved in the sale of streaming players, audio products, smart home products, and accessories that are sold through retailers and distributors, as well as directly to customers through the company’s website. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

ROKU is trending following an upgrade from Morgan Stanley, with the community discussing the potential for new 52-week highs as analysts point to accelerating platform revenue growth and industry tailwinds. Some traders are expressing caution, noting selective participation and the stock's history of fading gains, while others are optimistic about further upside and potential short squeezes. Broader conversations touch on streaming wars, ad spend trends, and potential acquisitions.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as investors discuss its partnerships and potential role in AI data centers, with some highlighting recent agreements with GlobalFoundries and Cyient Semiconductors. The community is weighing the company's growth prospects against its valuation and short interest, while monitoring potential catalysts like Elektra Awards and developments with Nvidia. Overall, the conversation revolves around whether NVTS can capitalize on the increasing demand for efficient power solutions in high-power applications.

Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Biodexa Pharmaceuticals Plc - ADR

Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals is trending due to aggressive upside momentum and high trading volume, with community members pointing to its low float and potential for significant price movement. Discussions revolve around potential entry points, resistance levels, and whether it can sustain its gains. The stock's volatility and previous patterns are also being actively discussed.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as investors react to jobs and retail sales data, with some interpreting the numbers as a sign of stagflation and a potential recession. Community members are debating the impact of the data on future rate cuts and discussing potential market direction, with some expressing skepticism about the strength of the economy. The conversation also includes discussion of AI stocks, and potential market manipulation.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as its community rallies around its resilient performance on the Solana network, highlighting its widely distributed supply and locked liquidity. Discussions emphasize the token's stability when $SOL dips and its USDC trading pair, which reduces volatility compared to other meme coins. The community expresses strong conviction in WAGMI's long-term growth and potential, citing its strong narrative and organic community.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MSCLF https://www.biospace.com/press-releases/satellos-announces-new-data-further-demonstrating-safety-tolerability-and-functional-impact-of-sat-3247-in-first-in-human-trial-of-adults-with-duchenne-muscular-dystrophy

Steve Tripp

fullmetalll

Adults with Duchenne muscular dystrophy demonstrated functional improvements exceeding natural history, following 28-day treatment with SAT-3247 Grip strength increased 118.6% and predicted forced vital capacity increased 5.8%; whereas, both decline in natural history SAT-3247 demonstrated safety, tolerability, and expected pharmacokinetics (PK) across all parts of Phase 1 a/b study New data presented in late-breaking poster session at the 30th Annual Congress of the World Muscle Society TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc.

BioSpace

Satellos Announces New Data Further Demonstrating Safety, Tolerability, and Functional Impact of SAT-3247 in First-in-Human Trial of Adults with Duchenne Muscular Dystrophy